Cerebricon Ltd

Cerebricon Ltd. is a provider of high quality and cost effective contract and collaborative preclinical models of CNS disease.

Cerebricon works as an extension of the discovery process and, when needed, as an independant validation body for the assessment of in-licensing candidates.

Contact Details: Cerebricon Limited207 West Los Angeles Avenue, # 355 Moorepark Massachusetts 93021 United States of America Tel: 1 805 990 6700 Fax: 1 805 523 8950 Email: info@cerebricon.com WWW: www.cerebricon.com/

Loading...

Recent Publications by Cerebricon Ltd:
Neuroprotective properties of the non-peptidyl radical scavenger IAC in rats following transient focal cerebral ischemia. Experimental evidence suggests that reactive free radicals are generated...	14th August, 2008	Cerebricon Ltd, Finland.	Brain Res. 2008 May 1;1207:174-81. Epub 2008 Feb 21. DOI Direct Link
Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Statins exert beneficial effects in brain diseases including stroke. Here,...	28th October, 2005	Cerebricon Ltd, Microkatu 1, Kuopio, Finland.	Brain Res. 2005 Aug 9;1052(2):174-9. DOI Direct Link

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 289 times since April 2007, the link to the organisation's website has been followed 50 times

Recent Search Terms used to find this page: cerebricon | .

Search for more companies in Moorepark

Search for more companies in Massachusetts

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cerebricon Ltd